Alphatec HoldingsATEC +0.74%62 Debt-to-EBITDA is -89.80 as of Mar. 2026. GuruFocus rates ATEC with a GF Score™ of 62/100 and a GF Value™ of $15.38 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 470 Medical Devices & Instruments companies, Alphatec Holdings ranks worse than 99.57% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Alphatec Holdings's Debt-to-EBITDA or its related term are showing as below:
ATEC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -39.96 Med: -3.48 Max: 94.9
Current: 94.9
During the past 13 years, the highest Debt-to-EBITDA Ratio of Alphatec Holdings was 94.90. The lowest was -39.96. And the median was -3.48.
ATEC's Debt-to-EBITDA is ranked worse than 99.57% of 470
companies
in the Medical Devices & Instruments industry
Industry Median: 1.585
vs ATEC: 94.90
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Alphatec Holdings Debt-to-EBITDA Related Terms
Alphatec Holdings Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Alphatec Holdings's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATEC vs IART, AHCO, INSP: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Alphatec Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alphatec Holdings Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Alphatec Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Alphatec Holdings (ATEC) has a Debt-to-EBITDA of -89.80 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Alphatec Holdings. According to the industry distribution chart, Alphatec Holdings ranks #468 out of 470 companies in the Medical Devices & Instruments industry, placing it in the top 99.6%.
Is Alphatec Holdings' Debt-to-EBITDA too high?
Alphatec Holdings' current Debt-to-EBITDA is -89.80. Based on the distribution chart, Alphatec Holdings ranks #468 out of 470 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Alphatec Holdings has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Alphatec Holdings' Debt-to-EBITDA compare to IART and AHCO?
According to the Medical Devices & Instruments industry distribution chart, Alphatec Holdings ranks #468 out of 470 companies for Debt-to-EBITDA. This places Alphatec Holdings in the lower half of its industry. The industry median Debt-to-EBITDA is 1.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.59, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Alphatec Holdings. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alphatec Holdings's current Debt-to-EBITDA is -89.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alphatec Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alphatec Holdings (ATEC) is currently considered Possible Value Trap. The stock's GF Value™ is $15.38, compared to a current price of $9.59 — trading 37.6% below its estimated fair value. The current Debt-to-EBITDA is -89.80. Alphatec Holdings' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Alphatec Holdings (ATEC), the current Debt-to-EBITDA is -89.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alphatec Holdings (ATEC) Overvalued in 2026?
Based on GuruFocus' analysis, Alphatec Holdings stock appears to be undervalued.
The current stock price of $9.59 is trading 37.6% below its estimated GF Value™ of $15.38.
GuruFocus considers Alphatec Holdings to be Possible Value Trap.
Key valuation signals for ATEC:
Debt-to-EBITDA: -89.80
GF Value™: $15.38 vs. price of $9.59 (37.6% below fair value)
No single metric tells the full story. See the ATEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
62GF Score
Get the complete analysis for ATEC
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATEC has been successfully added to your 
